Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
544.52
+2.83 (0.52%)
At close: Aug 31, 2026, 4:00 PM EDT
545.80
+1.28 (0.24%)
After-hours: Aug 31, 2026, 7:58 PM EDT

Vertex Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
138,015126,073113,436115,026100,413114,326124,497103,707120,038120,955107,975104,84989,75090,63581,00274,12774,25572,06966,43755,83447,058
Market Cap Growth (YoY)
37.67%10.27%-8.88%10.91%-16.35%-5.48%15.30%-1.09%33.75%33.45%33.30%41.44%20.87%25.76%21.92%32.76%57.80%38.08%18.93%-9.15%-33.61%
Enterprise Value
126,351115,063103,152104,85189,912104,618115,02394,253110,783107,12395,06891,96577,92479,92971,12365,18165,84964,70459,87949,75041,244
Last Close Price
544.52496.73446.54453.36391.64445.20484.82402.70465.08468.72418.01406.89347.74351.91315.07288.78289.54281.79260.97219.60181.39

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
31.6928.6226.1529.1027.3231.43-125.89-193.63-250.18-26.8628.9725.8726.9424.8522.3122.6922.5627.1123.8421.62
Forward PE
27.3225.3623.3122.6120.3223.6026.8822.6626.3928.0724.8524.4421.9222.7021.8918.8319.6719.4518.1216.4214.48
PS Ratio
10.9610.029.289.588.5710.0111.229.4111.3011.7010.6010.629.309.548.808.308.548.638.367.376.60
PB Ratio
6.816.235.866.165.806.667.556.327.688.195.825.965.445.865.615.335.706.046.095.534.94
P/TBV Ratio
7.366.736.356.716.367.308.327.158.769.416.506.706.066.586.366.076.546.846.996.425.79
P/FCF Ratio
36.3633.2130.5736.0230.0932.67-99.57-131.22-108.55-29.0531.4221.3423.3720.8218.8919.4719.0327.1123.1824.52
P/OCF Ratio
32.1529.3726.7531.6827.0129.72-127.00-210.53-142.46-27.3829.6420.4922.2819.8917.9518.3517.9424.8021.1221.99
PEG Ratio
2.052.021.680.150.130.730.841.210.751.040.781.921.712.000.760.580.670.580.771.621.33

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
10.049.148.448.747.679.1610.368.5510.4310.369.339.328.078.417.727.307.577.757.536.575.79
EV/EBITDA Ratio
24.7722.5620.7121.5519.0822.7226.2220.5924.9124.3720.7420.5417.0517.2715.4014.4014.7414.7414.3412.3910.98
EV/EBIT Ratio
25.7423.4421.5122.3719.8223.6227.3221.4526.1425.5221.6121.3517.6717.8815.9214.8915.2315.2214.8112.7911.35
EV/FCF Ratio
33.2830.3127.8032.8326.9429.89-92.00-119.26-100.18-25.5727.5618.5320.6118.2816.6117.2717.0924.4320.6621.49

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.100.100.100.110.110.090.100.110.110.060.040.050.050.050.060.070.060.070.080.100.09
Debt / EBITDA Ratio
0.370.360.400.380.350.310.370.370.370.230.140.200.160.160.170.200.170.180.200.230.20
Debt / FCF Ratio
0.520.520.540.640.550.44-1.32-2.21-1.60-0.190.240.180.200.200.230.220.220.360.400.46
Net Debt / Equity Ratio
-0.58-0.58-0.57-0.55-0.59-0.61-0.59-0.58-0.60-0.63-0.75-0.73-0.78-0.76-0.74-0.72-0.69-0.70-0.67-0.65-0.64
Net Debt / EBITDA Ratio
-2.29-2.29-2.21-2.11-2.16-2.28-2.21-2.07-2.13-2.11-3.02-2.88-2.82-2.56-2.32-2.21-2.00-1.91-1.76-1.63-1.62
Net Debt / FCF Ratio
-3.07-3.07-2.97-3.22-3.05-3.007.7711.998.557.84-3.72-3.87-3.06-3.05-2.75-2.54-2.35-2.22-3.00-2.72-3.17
Asset Turnover
0.500.460.510.500.510.490.520.520.480.460.450.470.510.510.530.580.590.610.640.64
Inventory Turnover
3.473.363.143.483.563.884.194.985.096.205.836.686.997.698.119.219.899.619.799.508.59
Quick Ratio
2.542.542.382.241.842.002.122.172.082.103.153.603.743.823.954.464.284.144.374.044.21
Current Ratio
3.193.193.022.902.362.522.652.692.472.523.503.994.084.144.284.834.704.504.754.464.63
Return on Equity (ROE)
22.21%21.70%26.48%25.11%24.54%15.71%22.80%27.51%-86.28%24.35%22.73%25.90%24.50%19.75%24.32%29.82%28.39%29.02%31.38%36.39%
Return on Assets (ROA)
11.77%10.92%12.51%12.67%12.30%11.35%12.42%13.35%10.61%13.04%10.75%12.96%14.45%15.14%15.17%17.86%18.97%18.70%19.23%21.79%
Return on Invested Capital (ROIC)
7.04%6.65%8.39%8.20%7.66%7.61%7.80%9.29%9.84%12.86%12.91%18.54%18.27%19.96%19.82%23.97%25.34%23.33%25.36%24.94%
Return on Capital Employed (ROCE)
20.90%20.90%21.20%21.50%22.30%22.30%22.00%23.20%23.20%25.30%21.90%22.50%24.30%26.30%28.00%28.40%30.70%32.60%33.50%34.50%34.00%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Aug '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
3.19%3.49%3.82%3.44%3.66%3.18%-0.79%-0.52%-0.40%-0.40%3.72%3.45%3.87%3.71%4.02%4.48%4.41%4.43%3.69%4.20%4.63%
FCF Yield
2.75%3.01%3.27%2.78%3.32%3.06%-1.00%-0.76%-0.92%-0.98%3.44%3.18%4.69%4.28%4.80%5.29%5.14%5.25%3.69%4.31%4.08%
Buyback Yield / Dilution
0.85%1.43%1.23%1.69%1.30%-0.31%0.61%0.15%-0.15%0.88%-0.31%-0.23%-0.42%-0.66%-0.93%-1.28%0.08%0.88%1.53%2.32%1.66%
SEC Filings: 10-K · 10-Q